Literature DB >> 21326757

Complications of uterine fibroid embolization.

Brian E Schirf1, Robert L Vogelzang, Howard B Chrisman.   

Abstract

Uterine fibroid embolization (UFE) is an increasingly popular, minimally invasive treatment option for women with symptomatic fibroid disease. UFE therapy in qualified hands is an effective, well-tolerated procedure that offers relief of fibroid symptoms with a low risk of complications. In the acute postprocedural period, immediate complications may relate to vascular access, thromboembolic events, infection, and pain management. Reported major complications include but are not limited to pulmonary embolus, uterine ischemia, necrosis, sepsis, and death. Non-life-threatening complications include altered ovarian and sexual function, subcutaneous tissue necrosis, expulsion of fibroid tissue, and treatment failure. Awareness of the known complications of UFE may allow more rapid diagnosis and effective therapeutic responses to complications when they occur.

Entities:  

Keywords:  Fibroids; complications; embolization

Year:  2006        PMID: 21326757      PMCID: PMC3036365          DOI: 10.1055/s-2006-941444

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  25 in total

1.  Fatal septicaemia after fibroid embolisation.

Authors:  A Vashisht; J Studd; A Carey; P Burn
Journal:  Lancet       Date:  1999-07-24       Impact factor: 79.321

2.  Sexual dysfunction after uterine artery embolization.

Authors:  A C Lai; S C Goodwin; S M Bonilla; A P Lai; T Yegul; S Vott; M DeLeon
Journal:  J Vasc Interv Radiol       Date:  2000-06       Impact factor: 3.464

3.  Labial necrosis after uterine artery embolization for leiomyomata.

Authors:  Thomas J Yeagley; Jay Goldberg; Thomas A Klein; Joseph Bonn
Journal:  Obstet Gynecol       Date:  2002-11       Impact factor: 7.661

4.  Uterine artery embolization for leiomyomata.

Authors:  J B Spies; S A Ascher; A R Roth; J Kim; E B Levy; J Gomez-Jorge
Journal:  Obstet Gynecol       Date:  2001-07       Impact factor: 7.661

5.  The management of peripheral vascular complications associated with the use of percutaneous suture-mediated closure devices.

Authors:  L R Sprouse; D M Botta; I N Hamilton
Journal:  J Vasc Surg       Date:  2001-04       Impact factor: 4.268

6.  The effect of pelvic MR imaging on the diagnosis and treatment of women with presumed symptomatic uterine fibroids.

Authors:  Reed A Omary; Syam Vasireddy; Howard B Chrisman; Robert K Ryu; F Scott Pereles; James C Carr; Scott A Resnick; Albert A Nemcek; Robert L Vogelzang
Journal:  J Vasc Interv Radiol       Date:  2002-11       Impact factor: 3.464

7.  Complications after uterine artery embolization for leiomyomas.

Authors:  James B Spies; Amy Spector; Antoinette R Roth; Chandra M Baker; Lauren Mauro; Kerry Murphy-Skrynarz
Journal:  Obstet Gynecol       Date:  2002-11       Impact factor: 7.661

8.  Anastomoses of the ovarian and uterine arteries: a potential pitfall and cause of failure of uterine embolization.

Authors:  M Matson; A Nicholson; A M Belli
Journal:  Cardiovasc Intervent Radiol       Date:  2000 Sep-Oct       Impact factor: 2.740

9.  The FIBROID Registry: symptom and quality-of-life status 1 year after therapy.

Authors:  James B Spies; Evan R Myers; Robert Worthington-Kirsch; Jyotsna Mulgund; Scott Goodwin; Matthew Mauro
Journal:  Obstet Gynecol       Date:  2005-12       Impact factor: 7.661

10.  Transient ovarian failure: a complication of uterine artery embolization.

Authors:  P Amato; A C Roberts
Journal:  Fertil Steril       Date:  2001-02       Impact factor: 7.329

View more
  9 in total

Review 1.  What is too big? Uterine artery embolization of a large fibroid causing abdominal compartment syndrome.

Authors:  Claire Kaufman; Jeffery Pollak; Hamid Mojibian
Journal:  Semin Intervent Radiol       Date:  2014-06       Impact factor: 1.513

2.  Clinical care of patients undergoing uterine artery embolization.

Authors:  Thuong G Van Ha; Natasha Li
Journal:  Semin Intervent Radiol       Date:  2006-12       Impact factor: 1.513

Review 3.  A Systematic Review of Minimally Invasive Treatments for Uterine Fibroid-Related Bleeding.

Authors:  Jiahui Zhang; Virginia-Arlene Go; Jaime Friel Blanck; Bhuchitra Singh
Journal:  Reprod Sci       Date:  2021-09-03       Impact factor: 2.924

4.  Clinical outcomes of uterine artery embolization and experience of postoperative transvaginal fibroid expulsion: a retrospective analysis.

Authors:  Ruo-Li Wang; Qi-Tian Fu; Jian Jiang; Dan-Dan Ruan; Jia-Li Lin; Yi Tang; Yan-Feng Zhou; Shao-Jie Wu; Sen-Lin Cai; Jian-Hui Zhang; Jie-Wei Luo; Zhu-Ting Fang
Journal:  Arch Gynecol Obstet       Date:  2022-02-05       Impact factor: 2.493

5.  Uterine artery pseudoaneurysm with an anastomotic feeding vessel requiring repeat embolisation.

Authors:  Clara Q Wu; Mohammed Nayeemuddin; Darrien Rattray
Journal:  BMJ Case Rep       Date:  2018-07-11

6.  Assessing burden, risk factors, and perceived impact of uterine fibroids on women's lives in rural Haiti: implications for advancing a health equity agenda, a mixed methods study.

Authors:  Christophe Millien; Anatole Manzi; Arlene M Katz; Hannah Gilbert; Mary C Smith Fawzi; Paul E Farmer; Joia Mukherjee
Journal:  Int J Equity Health       Date:  2021-01-01

Review 7.  Transradial Embolization, an Underused Type of Uterine Artery Embolization Approach: A Systematic Review.

Authors:  Loredana Maria Maria Himiniuc; Mara Murarasu; Bogdan Toma; Razvan Popovici; Ana-Maria Grigore; Ioana-Sadiye Scripcariu; Mihaela Oancea; Mihaela Grigore
Journal:  Medicina (Kaunas)       Date:  2021-01-20       Impact factor: 2.430

8.  Uterus-preserving management of pyomyoma: Case report of a rare complication after uterine artery embolization.

Authors:  Jana Busshoff; Fabinshy Thangarajah; Bernd Morgenstern
Journal:  Case Rep Womens Health       Date:  2022-03-21

9.  The role of magnetic resonance-guided focused ultrasound in fertility-sparing treatment of uterine fibroids-current perspectives.

Authors:  Michał Ciebiera; Tomasz Łoziński
Journal:  Ecancermedicalscience       Date:  2020-05-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.